Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis.
about
Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imagingThe pemetrexed-containing treatments in the non-small cell lung cancer is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: a meta-analysisTargeted therapy for hepatocellular carcinoma: novel agents on the horizonClinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and futureMolecular therapies in hepatocellular carcinoma: what can we target?What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis?Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation studyAssociation of 677 C>T (rs1801133) and 1298 A>C (rs1801131) polymorphisms in the MTHFR gene and breast cancer susceptibility: a meta-analysis based on 57 individual studiesPrognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis.Can TIE-2 expressing monocytes represent a novel marker for hepatocellular carcinoma?Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.Expression characteristics of KAI1 and vascular endothelial growth factor and their diagnostic value for hepatocellular carcinomaChanges in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma.Utilisation of search filters in systematic reviews of prognosis questions.Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).Multiple regulatory mechanisms of hepatocyte growth factor expression in malignant cells with a short poly(dA) sequence in the HGF gene promoter.The 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies.Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinomaSoluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment.Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patientsHepatocellular carcinoma: From diagnosis to treatment.Prognostic Value of VEGF in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Meta-Analysis.PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism.VEGF is associated with the poor survival of patients with prostate cancer: a meta-analysis.Systemic therapy in hepatocellular carcinoma.Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis.A meta-analysis of gemcitabine biomarkers in patients with pancreaticobiliary cancers.Bridging Sunitinib Exposure to Time-to-Tumor Progression in Hepatocellular Carcinoma Patients With Mathematical Modeling of an Angiogenic Biomarker.Prognostic significance of regulatory T lymphocytes in patients with hepatocellular carcinomaMolecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment.Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysisSerum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis.Pazopanib: an antiangiogenic drug in perspective.Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma.Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implicationsSorafenib: activity and clinical application in patients with hepatocellular carcinoma.Hypoxia-mediated biological control.Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review.Pathways and targets in hepatocellular carcinoma.
P2860
Q26783895-433FF039-FC12-41F4-BAFE-39F897992D0FQ26999925-F99F3BB6-0169-4244-934D-3B62D307F6A1Q27002288-7F04CD2C-20CD-4915-AF8C-7C1B461494C2Q27013055-E90EF3C7-BF90-46BD-815E-4A068DEDC334Q27025381-027D784E-E183-4FD9-A681-F1AC710E6A10Q30908529-7B4211CF-B16E-4730-818E-3D0B5FEECF75Q33441170-C306FDA0-50C5-49F1-BBAA-331D1F99A554Q33778852-9D0AB35B-8DF9-48D9-97B8-DA1ADB74AB57Q34019881-0068F87D-4328-4A98-A424-5FAF20CC69CBQ34077177-AAC75122-C317-433D-82F2-61AD62ED1BCEQ34131801-307E8752-6AAD-47B0-B336-1A6C2AE9A778Q34182116-B422F19A-AB39-4930-B9D2-6DEC72B501F8Q34402650-E7C6BF24-A3D9-4366-881B-3B9059EC9AE7Q34486542-76017270-64A3-4618-911B-4E7D2513429FQ34517849-2301A37E-6541-441E-B7C4-06D08FDFBEBCQ34582447-90BF7331-E545-4CD8-8C8A-9A3BE39E3A21Q34598131-5482B828-0146-43EE-944A-BB41617399DAQ34681150-14B53166-15CA-4F32-9F67-B9D817271E6EQ35053561-77238927-9266-4FFA-AC88-6D87F495CF74Q35625455-31FBFDBB-C0FD-4BE0-90CB-764C7D8DC71FQ35668716-DE8B549B-310F-46C7-8730-CB753F15184DQ35811557-AF40C7C2-D156-407E-A998-F4664F0148D1Q36211287-752EE786-875B-4F04-BFA2-8B445E36C409Q36450743-34AD5B1C-37D3-415E-9B62-EFF0A4173BFBQ37135733-13B78631-D02D-4899-824B-0EBE358E762EQ37163407-C13A877E-CB49-4A83-8D61-EAFDADE2E581Q37268613-102B8E87-3341-441C-A1F1-D6DF443FC919Q37461714-D5DA9CAA-6A50-4798-A5C3-B2E42AB7517BQ37520016-BC00927F-BD2E-4088-884D-491D455F8CD0Q37581359-D1280F32-CD91-4843-81AC-D6FE5DE0E192Q37584674-9A29E493-9979-4CC3-911D-B2DA6B08563EQ37584706-66B65707-FD48-43A9-BA66-8D31F6C88958Q37630567-DD5E0A9B-F3EE-4AE3-81C2-1549F578DE0AQ37657319-84DC93B7-2EFE-47F6-8E54-B5B454451E67Q37706763-62F63880-772E-428B-83BF-C36AEFD17243Q37827878-94ABE93B-FA6F-4908-A637-391B793BDCF6Q37843943-177E5C03-4BFD-42A2-A5C1-DFE6FC8211ABQ37914630-45F145D1-D039-424B-BDB1-471B5D521C39Q37978530-B31A57EA-B00C-44BB-BF6D-549D908CE6DDQ38062022-E0DB1390-1CF8-499A-853D-61ABCF4730C5
P2860
Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic role of vascular en ...... atic review and meta-analysis.
@en
Prognostic role of vascular en ...... atic review and meta-analysis.
@nl
type
label
Prognostic role of vascular en ...... atic review and meta-analysis.
@en
Prognostic role of vascular en ...... atic review and meta-analysis.
@nl
prefLabel
Prognostic role of vascular en ...... atic review and meta-analysis.
@en
Prognostic role of vascular en ...... atic review and meta-analysis.
@nl
P2093
P2860
P31
P921
P356
P1476
Prognostic role of vascular en ...... atic review and meta-analysis.
@en
P2093
J A Talwalkar
L R Roberts
S J Schoenleber
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605017
P407
P577
2009-05-01T00:00:00Z
2009-05-05T00:00:00Z